Karmanos Cancer Institute, first cancer center in Michigan to offer CAR-T Therapy for an aggressive type of non-Hodgkin Lymphoma
DETROIT, March 27, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute in Detroit is the first center in Michigan approved to treat adult patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL) with the commercially approved chimeric …